載入...
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
BACKGROUND: Omalizumab may modulate airway remodeling in severe asthma. Using forced expiratory volume in 1 second (FEV(1)) as a surrogate of airway remodeling, we aimed to investigate if an omalizumab add-on in severe allergic asthma may lead to a persistent reversal of airway obstruction and to ev...
Na minha lista:
| 發表在: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475845/ https://ncbi.nlm.nih.gov/pubmed/31002021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619841274 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|